SOURCE: Morley Research

December 07, 2010 13:32 ET

Two Atlanta Business Leaders Appointed to Board of India-US Business Network

ATLANTA, GA--(Marketwire - December 7, 2010) - Jane Green, PhD, president of Morley Research Consortium, and Donald Johnson, Chief Operations Officer of Opus Institutional Review Board, have been appointed to the India-US Business Network (IUSBN) Board of Directors.

In this capacity Dr. Green and Mr. Johnson will be integral to shaping the relationship between India and the United States as the two countries explore and develop mutually beneficial opportunities. The initial four areas of interest for the IUSBN are Biotech, Pharma, Diagnostic, Devices and Health Care; Cold Chain; Education; and Renewable Energy. 

The two Atlanta leaders, who both have extensive experience in clinical research, have been asked to sit on the Biotech Committee for the IUSBN. This committee is focused on matching companies from each country with counterparts in research and development.

"This is both an honor and an opportunity," said Dr. Green. "By furthering cooperation with India, we achieve the ability to improve the level of research and development in the area of biotech in both countries. I believe this exchange of ideas and information can create exponential advances in developing products and technologies that will benefit the entire world."

Dr. Green's organization, the Morley Research Consortium, assists device and drug companies to achieve their research goals of bringing a new product to market through its contract research organization which additionally provides research compliance, total trial management, contracting, site identification and training.

"India is a world leader in technology innovations, and expects to achieve similar success in the biotech field," said Mr. Johnson. "I am pleased to be able to play a role in helping reach that goal, while also strengthening and benefiting U.S. companies."

Mr. Johnson manages Opus Institutional Review Board (IRB), the ethical overview organization mandated to review clinical research studies worldwide. Opus IRB has a board of directors consisting of the country's top practicing physicians in a variety of clinical specialties and encompasses over 20 medical disciplines.

Mr. Johnson and Dr. Green are the first two board members of the IUSBN from the southern region of the U.S. and they are planning the initial Atlanta area meeting of the IUSBN in the first quarter 2011 for others interested in the organization.

Learn more about IUSBN at www.iusbn.org

Contact Information